MR-Guideline? [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2010-04-23 14:34 (5536 d 22:48 ago) – Posting: # 5197
Views: 23,323

Dear Marcel!

You did not dig deep enough. At the end of the table on page 60 it is stated:
CPMP/EWP/280/96 – Note for guidance on Modified Release Oral and Transdermal Dosage Forms: Section II – Revision to be considered

❝ If this is still the case, in your opinion can we expect a draft guidance out in 2010?


Don’t know. I’m not optimistic for a draft that early. As an example: regulators talked at conferences about a revision of the (IR)BE-GL in mid-2004, the Q&A was published as some kind of ‘intermediate’ in 2006, the ‘Recommendation on the Need for Revision of NfG on BA/BE’ in 2007, and the draft in 2008…

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,677 registered users;
39 visitors (0 registered, 39 guests [including 7 identified bots]).
Forum time: 13:22 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5